World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
58322
World Ranking
10243
National Ranking
984

Overview

Judith M. Bliss is affiliated with the Institute of Cancer Research in the United Kingdom. Their research primarily focuses on oncology, with significant contributions in breast cancer treatment studies and cancer genomics. The work spans medicine, biochemistry, genetics, and molecular biology, with particular emphasis on subfields such as oncology, cancer research, pulmonary and respiratory medicine, genetics, and molecular biology.

Notable recent publications by Judith M. Bliss include:

  • Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial, 2020, The Lancet
  • Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer, 2022, Annals of Oncology
  • Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial, 2020, The Lancet Oncology
  • Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13,864 women in seven randomised trials, 2021, The Lancet Oncology
  • Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial, 2020, The Lancet Oncology

Frequent co-authors in their research include:

  • Lucy Kilburn
  • David Cameron
  • Nicholas C. Turner
  • Charlotte E. Coles
  • Holly Tovey

The primary venues where Judith M. Bliss publishes are:

  • Cancer Research
  • Journal of Clinical Oncology
  • Annals of Oncology
  • Radiotherapy and Oncology
  • Clinical Cancer Research

Their research topics highlight areas such as:

  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • Cancer Genomics and Diagnostics
  • Estrogen and related hormone effects
  • HER2/EGFR in Cancer Research
  • Advanced Radiotherapy Techniques
  • Advances in Oncology and Radiotherapy

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

    C Focan;SM Steinberg;M Blichert-Toft;JF Forbes

  • A Randomized Trial Of Exemestane After Two To Three Years Of Tamoxifen Therapy In Postmenopausal Women With Primary Breast Cancer.

    R. C Coombes;E. Hall;L. J. Gibson;R. Paridaens

  • A pooled analysis of bone marrow micrometastasis in breast cancer

    Stephan Braun;Florian D. Vogl;Bjørn Naume;Wolfgang Janni

  • The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials

    Joanne S Haviland;Joanne S Haviland;J Roger Owen;John A Dewar;Rajiv K Agrawal

  • The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

    Bentzen Sm;Agrawal Rk;Aird Eg

  • Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

    RC Coombes;LS Kilburn;CF Snowdon;R Paridaens

  • Influence of psychological response on survival in breast cancer: a population-based cohort study.

    M Watson;M Watson;JS Haviland;S Greer;J Davidson

  • Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

    Mitch Dowsett;Jack Cuzick;Jim Ingle;Alan Coates

  • The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

    Bentzen Sm;Agrawal Rk;Aird Eg

  • The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer.

    Stirling Moorey;Steven Greer;Maggie Watson;Christine Gorman

  • Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Bernard Asselain;William Barlow;John Bartlett;Jonas Bergh

  • Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.

    Adrian Murray Brunt;Adrian Murray Brunt;Joanne S Haviland;Duncan A Wheatley;Mark A Sydenham

  • Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

    J. Bergh;K. Pritchard;K. Albain;S. Anderson

  • Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: The TNT Trial

    Andrew Tutt;Andrew Tutt;Holly Tovey;Maggie Chon U Cheang;Sarah Kernaghan

  • Adjuvant psychological therapy for patients with cancer: a prospective randomised trial.

    S. Greer;S. Moorey;J. D. R. Baruch;M. Watson

  • Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial

    J Roger Owen;Anita Ashton;Judith M Bliss;Janis Homewood

  • Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer

    Charlotte Fribbens;Ben O’Leary;Lucy Kilburn;Sarah Hrebien

  • Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial

    John Yarnold;Anita Ashton;Judith M Bliss;Janis Homewood

  • Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

    Tom Treasure;Loic Lang-Lazdunski;David Waller;Judith M Bliss

Frequent Co-Authors

John Yarnold
John Yarnold Institute of Cancer Research
Mitch Dowsett
Mitch Dowsett Breast Cancer Research Foundation
Nicholas C. Turner
Nicholas C. Turner Royal Marsden NHS Foundation Trust
Robert E. Coleman
Robert E. Coleman University of Sheffield
Andrew Tutt
Andrew Tutt Institute of Cancer Research
Maggie C.U. Cheang
Maggie C.U. Cheang Institute of Cancer Research
Maggie Watson
Maggie Watson University of Strathclyde
R. Charles Coombes
R. Charles Coombes Imperial College London
John F.R. Robertson
John F.R. Robertson University of Nottingham
Jacek Jassem
Jacek Jassem Gdańsk Medical University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you explore a career in medicine, related healthcare degrees offer flexible and affordable entry points. Many students begin their journeys with affordable nursing programs online. These programs are well-suited for those balancing work or family commitments while pursuing a nursing credential.

For those who are already Registered Nurses (RNs), rn to bsn online programs provide a streamlined path to advance qualifications and expand career options. Similarly, aspiring advanced practice providers can look into nurse practitioner programs that are available online. These programs open doors to higher responsibility and autonomy in patient care settings.

Those interested in research, leadership, or academia might consider an online nursing doctorate. Doctorate programs enable graduates to teach at the university level, lead healthcare innovations, or influence public health policy.

Exploring these online degrees and pathways can help you achieve your career goals—whether you're just starting in healthcare or seeking to specialize further.

Best Scientists Citing Judith M. Bliss

Trending Scientists